Published in Heart on May 01, 2001
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation (1995) 8.62
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart (2001) 3.88
The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17
Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation (1995) 2.88
Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation (1997) 2.52
Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation (1997) 2.44
Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res (1997) 2.26
Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol (1991) 2.02
Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation (1996) 1.75
Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol (2000) 1.64
Do patients over 40 years of age benefit from surgical closure of atrial septal defects? Heart (2001) 1.61
Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation (1997) 1.51
Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man. Eur Heart J (1999) 1.50
Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. Eur Heart J (1987) 1.45
Subsecond multi-slice computed tomography: basics and applications. Eur J Radiol (1999) 1.41
Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol (1997) 1.41
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation (1997) 1.37
Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation (1998) 1.33
Endothelial function and nitric oxide: clinical relevance. Heart (2001) 1.32
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol (1991) 1.32
Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol (1998) 1.22
Atrial electrophysiologic remodeling: another vicious circle? J Cardiovasc Electrophysiol (1998) 1.21
Effect of atrial fibrillation on atrial refractoriness in humans. Circulation (1996) 1.11
Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther (1989) 1.07
Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation (1997) 1.07
Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res (1999) 1.06
The effects of changes to action potential duration on the calcium content of the sarcoplasmic reticulum in isolated guinea-pig ventricular myocytes. Pflugers Arch (1997) 1.01
Stable versus unstable atherosclerosis: clinical aspects. Am Heart J (1999) 0.97
Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol (1999) 0.97
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. Circulation (1998) 0.96
Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol (1997) 0.96
Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation (1996) 0.96
How should patients with patent foramen ovale be managed? Heart (2001) 0.95
Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation (2000) 0.93
[Cardiac multidetector-row CT: first clinical results of retrospectively ECG-gated spiral with optimized temporal and spatial resolution]. Rofo (2000) 0.91
Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation (1999) 0.89
The effect of an increase in aortic pressure upon the inotropic state of cat and dog left ventricles. J Physiol (1977) 0.89
Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol (1999) 0.88
Norepinephrine release and left ventricular pressure in the isolated heart. Circ Res (1966) 0.86
Lesion morphology assessed by pre-interventional intravascular ultrasound does not predict the incidence of severe coronary artery dissections. Eur Heart J (1998) 0.85
Sympatholytic action of intravenous amiodarone in the rat heart. Circulation (1995) 0.84
Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation (1999) 0.84
Dependence of myocardial blood flow and metabolism on cardiac innervation. Cardiovasc Res (1978) 0.84
Recovery of the right atrial effective refractory period after cardioversion of chronic atrial fibrillation. Am J Cardiol (1999) 0.79
Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. Arch Intern Med (1983) 0.79
Effect of adrenergic blockade on pressure-related ventricular arrhythmias. Acta Cardiol (1991) 0.79
Change of atrial refractory period after short duration of rapid atrial pacing: regional differences and possible mechanisms. Pacing Clin Electrophysiol (1999) 0.78
Cerebral protection with filter devices during carotid artery stenting. Circulation (2001) 1.96
Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. Eur Heart J (2002) 1.52
Diagnostic value of stored electrograms in single-lead VDD systems. Pacing Clin Electrophysiol (2000) 0.96
Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart (2004) 0.94
Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure? Haemostasis (1983) 0.89
[Prevalence of arterial hypertension in the community. Experience of the province of Veneto]. G Ital Cardiol (1980) 0.85
Transient complete atrioventricular block during transcatheter ablation of a left inferoparaseptal anomalous pathway in a patient with a history of previous surgical repair of ventricular septal defect. Pacing Clin Electrophysiol (2001) 0.84
Blood pressure and metabolic profile after surgical menopause: comparison with fertile and naturally-menopausal women. J Hum Hypertens (2000) 0.84
Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study. Am J Hypertens (1995) 0.83
Electrophysiological properties of the atrioventricular node and ageing: evidence of a lower incidence of dual nodal pathways in the elderly. Europace (2001) 0.82
Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2013) 0.82
Cardiovascular neural regulation during and after prolonged high altitude exposure. Eur Heart J (1994) 0.81
[The behavior of the arterial pressure at rest and under exertion in normotensive and hypertensive subjects exposed to acute hypoxia at a median altitude]. G Ital Cardiol (1991) 0.81
Possible role of a ventricular conduction disturbance in the electrogenesis of the ECG-VCG signs of myocardial infarction. J Electrocardiol (1983) 0.80
Renal histologic and ultrastructural findings in psychogenic polydipsia and diabetes insipidus. Nephron (1976) 0.80
Solubilization of lipid bilayers by myristyl sucrose ester: effect of cholesterol and phospholipid head group size. Chem Phys Lipids (2008) 0.79
Structural abnormalities and not diastolic dysfunction are the earliest left ventricular changes in hypertension. HARVEST Study Group. Am J Hypertens (1998) 0.79
[The endocavitary and transesophageal electrophysiological findings in idiopathic atrial fibrillation]. G Ital Cardiol (1991) 0.78
Glycaemic fall after a glucose load. A population-based study. Nutr Metab Cardiovasc Dis (2009) 0.78
The role of left ventricular conduction in the electrogenesis of left ventricular hypertrophy. An electrophysiologic study in man. Circulation (1979) 0.78
Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation. J Interv Card Electrophysiol (2012) 0.78
Cardiovascular adaptations to endurance training and detraining in young and older athletes. Int J Cardiol (1998) 0.77
The effects of alcohol consumption on ambulatory blood pressure and target organs in subjects with borderline to mild hypertension. HARVEST Study Group. Am J Hypertens (1998) 0.77
[Accelerated idioventricular rhythm wih isorhythmic A-V dissociation. An electrophysiological study (author's transl)]. G Ital Cardiol (1980) 0.77
Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White syndrome. Eur Heart J (1988) 0.76
Right bundle branch block, intermittent ST segment elevation and inducible ventricular tachycardia in an asymptomatic patient: an unusual presentation of the Brugada syndrome? G Ital Cardiol (1998) 0.76
Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hypertens (1995) 0.76
Evidence of myocardial dysfunction in Bartter's syndrome. Am J Nephrol (1997) 0.75
[The ST/HR slope and coronary stenoses]. G Ital Cardiol (1993) 0.75
[Calculation of sino-atrial conduction time with the modified Narula technic. Comparison with the Strauss technic]. Boll Soc Ital Cardiol (1978) 0.75
[Post-ischemic inversion of the T wave]. G Ital Cardiol (1985) 0.75
The duration of atrial fibrillation influences the long-term efficacy of low-energy internal cardioversion. Ital Heart J (2001) 0.75
[Empiric treatment with amiodarone in patients with sustained ventricular tachyarrhythmia. Results of a long-term follow-up]. G Ital Cardiol (1990) 0.75
[Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test]. G Ital Cardiol (1991) 0.75
Mid-diastolic intraventricular functional block. A new mechanism for intermittent intraventricular blocks? G Ital Cardiol (1984) 0.75
[Value of serial electropharmacologic tests in the treatment of sustained ventricular arrhythmias]. G Ital Cardiol (1986) 0.75
[Progress of electrocardiography and vectorcardiography in the past 10 years]. G Ital Cardiol (1981) 0.75
[The right ventricular activation in ventricular activation delays. An endocardial mapping study (author's transl)]. G Ital Cardiol (1981) 0.75
Electrogenesis of the S1S2S3 electrocardiographic pattern. A study in humans based on body surface potential and right ventricular endocardial mapping. J Electrocardiol (1990) 0.75
Liver transplantation. A summary of our surgical practice. Chir Ital (1999) 0.75
[Bacterial endocarditis: prophylactic use of antibiotics in the dental patient]. G Stomatol Ortognatodonzia (1987) 0.75
[Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature]. G Ital Cardiol (1985) 0.75
[Clinical problems in patients with cardiac pre-excitation of the WPW type]. Cardiologia (1988) 0.75
[Study of right ventricular activation with the endocardiac mapping technic in subjects with normal QRS and with right branch block]. Boll Soc Ital Cardiol (1980) 0.75
[Different degrees of risk of high-frequency atrial fibrillation in symptomatic and asymptomatic WPW syndrome. Electrophysiologic evaluation]. G Ital Cardiol (1987) 0.75
[The reliability of Narula's technique for the evaluation of sino-atrial conduction time. Comparison with Strauss' technique and proposal of a new equation (author's transl)]. G Ital Cardiol (1980) 0.75
[Extrahospital cardiac arrest: the experience of Mestre Emergency Service]. G Ital Cardiol (1998) 0.75
[Behavior of intercellular pH in chronic uremia]. Minerva Nefrol (1971) 0.75
[Predictive value of the ajmaline test in dysfunction of the sinus node. Prospective 4-year follow-up relative to 77 patients]. G Ital Cardiol (1985) 0.75
Fluorescence studies of ATP-diphosphohydrolase from Solanum tuberosum var. Desirée. Phytochemistry (2000) 0.75
Activation mapping to determine the mechanism of atrial tachycardia when pacing techniques are not feasible. Minerva Cardioangiol (2012) 0.75
[Indications and limitations of ECG and VCG]. G Ital Cardiol (1979) 0.75
[Clinical value of sino-atrial conduction time]. G Ital Cardiol (1979) 0.75
[Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion]. G Ital Cardiol (1989) 0.75
Intracellular pH and electrolyte content of skeletal muscle in patients with chronic acidosis. Nephron (1970) 0.75
[Reliability of calculation of sino-atrial conduction time (SACT) with the modified Narula technic]. Boll Soc Ital Cardiol (1979) 0.75
The anterior displacement of the QRS loop as a right ventricular conduction disturbance. Electrophysiologic and vectorcardiographic study in man. J Electrocardiol (1980) 0.75
[Intrinsic function of the sinus node in patients with syncope and positive vagal maneuvers]. G Ital Cardiol (1984) 0.75
[Rate responsive electrostimulation. Recent findings]. G Ital Cardiol (1986) 0.75
[Distributions, mean values and correlations of various coronary risk factors in a population of Veneto]. G Ital Cardiol (1988) 0.75
[Multicenter evaluation of the antihypertensive action of prazosin]. Minerva Cardioangiol (1982) 0.75
Differences in nucleotide-binding site of isoapyrases deduced from tryptophan fluorescence. Phytochemistry (2003) 0.75
Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective. Am J Cardiol (1997) 0.75
[Not Available]. Herzschrittmacherther Elektrophysiol (2000) 0.75
A polarographic study of the photodegradation of nitrendipine. J Pharm Biomed Anal (1990) 0.75
[Disturbances of AV and/or IV conduction in sick sinus syndrome. Prevalence, evolution and clinical significance]. G Ital Cardiol (1983) 0.75
[Exchangeable sodium, water spaces and arterial pressure in chronic uremia. Studies made with Na22, B482 and tritiated water]. Minerva Nefrol (1969) 0.75
[Evaluation of the efficacy and tolerability of sustained-release nifedipine in arterial hypertension. Continuous monitoring of arterial pressure]. Minerva Cardioangiol (1990) 0.75
[Considerations on the value and limits of treatment of chronic renal insufficiency with a hypoprotein diet and with a "synthetic" diet based on essential amino acids]. Minerva Med (1965) 0.75
Urinary NO2- and NO3- evaluation by an ion chromatography system. Biomed Chromatogr (1998) 0.75
[The intracellular pH in chronic uremia. I. Body intracellular pH]. G Clin Med (1968) 0.75
Studies on ATP-diphosphohydrolase nucleotide-binding sites by intrinsic fluorescence. Braz J Med Biol Res (2000) 0.75
[Clinical and prognostic value of evaluation of atrial vulnerability in an electrophysiological endocavitary and transesophageal study]. G Ital Cardiol (1990) 0.75
[Clinical significance of corrected sinus node recovery time and natural and unnatural history of sinus node dysfunctions. A four-year prospective follow-up of 101 cases]. G Ital Cardiol (1982) 0.75
[Changes in the content of water, electrolytes, glycogen and protein and nonprotein nitrogen in the skeletal muscle of uremic patients in intermittent hemodialytic treatment]. Minerva Nefrol (1970) 0.75
Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism. Ital Heart J (2000) 0.75
[The effects of enalapril on basal arterial pressure at rest and during exercise and on cardiac performance in hypertensive athletes]. G Ital Cardiol (1990) 0.75